In our study, the serum apoA-1 and hepatic apoA-1 mRNA expressions were significantly increased in the obesity-insulin resistance rats after the FO intervention, and there was no statistical change between the CHF and PO. The gene discussed is APOA1; the disease is congestive heart failure.